References
1. EuropeanCommission, Pharmaceutical Strategy for Europe , D.
SANTE, Editor. 2020: Brussels.
2. EMA, EMA Regulatory Science to 2025. Strategic reflection.2020.
3. EMA, PROCEDURE FOR EUROPEAN UNION GUIDELINES AND RELATED
DOCUMENTS WITHIN THE PHARMACEUTICAL LEGISLATIVE FRAMEWORK , inDoc. Ref. EMEA/P/24143/2004 Rev. 1 corr E.M. Agency, Editor.
2009: London.
4. EuropeanCommission, Better Regulation Guidelines . 2021,
EuropeanCommission: Brussels.
5. Afonso, O., S. Monteiro, and M. Thompson, A growth model for
the quadruple helix. Journal of Business Economics and Management,
2012. 13 (5): p. 849-865.
6. Stier, J. and S.E. Smit, Co-creation as an innovative setting
to improve the uptake of scientific knowledge: overcoming obstacles,
understanding considerations and applying enablers to improve scientific
impact in society. Journal of innovation and entrepreneurship, 2021.10 (1): p. 35-35.
7. EuropeanCommission, Better Regulation Toolbox: Chapter 6 - How
to carry out and evaluation and fitness check . 2021, European
Commission: Brussels.
8. WHO Expert Committee on Specifications for Pharmaceutical
Preparations: fifty-fifth report . 2021: World Health Organization.
9. Atkinson, R.D., Understanding the US national innovation
system. ITIF, June, 2014.
10. OECD, Regulatory Impact Assessment . 2020.
11. EMA. Scientific publications . n.d.; Available from:
https://www.ema.europa.eu/en/news-events/publications/scientific-publications.
12. Kondo, T., et al., Evolving Vision of Regulatory Science in
the Global Medical Community. Clinical Pharmacology & Therapeutics,
2020. 107 (1): p. 136-139.
13. Leufkens, H.G., Regulatory science: Regulation is too
important to leave it to the regulators. Br J Clin Pharmacol, 2020.86 (12): p. 2333-2334.
14. Breckenridge, A., Regulatory Frameworks in Times of
Uncertainty. Clinical Pharmacology & Therapeutics, 2019.105 (3): p. 553-554.
15. Boyd, A., Commentary on ”Regulatory Science and Innovation
Programme for Europe (ReScIPE): A proposed model”. Br J Clin Pharmacol,
2021. 87 (10): p. 3647-3648.
16. Starokozhko, V., et al., Strengthening regulatory science in
academia: STARS, an EU initiative to bridge the translational gap. Drug
Discov Today, 2021. 26 (2): p. 283-288.
17. High, K.A., Turning genes into medicines-what have we learned
from gene therapy drug development in the past decade? Nature
Communications, 2020. 11 (1).